HC Wainwright reaffirmed their buy rating on shares of GT Biopharma (OTCMKTS:GTBP – Get Rating) in a research note issued to investors on Monday, Benzinga reports. The firm currently has a $5.00 target price on the stock. HC Wainwright also issued estimates for GT Biopharma’s Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at […]
U.S.-Russia Rift Complicates Case of Arrested Journal Reporter WASHINGTON-Moscow's arrest of a Wall Street Journal reporter on espionage charges this week broadens a rift between the U.S. and Russia that is already so wide, the two nuclear powers b. | 06:20am
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma (OTCMKTS:GTBP – Get Rating) is scheduled to post its quarterly earnings results on Monday, March 27th. GT Biopharma Trading Up 0.9 % OTCMKTS:GTBP opened at $0.63 on Friday. GT Biopharma has a 12-month low of $0.47 and a 12-month high of $3.29. The stock’s 50 day simple moving average is $0.75 and its […]
North American Morning Briefing: Stock Futures -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.